HealthStream (NASDAQ:HSTM) Shares Up 11.7% Following Better-Than-Expected Earnings

Key Points

• Shares rose 11.7% after HealthStream reported Q1 results that beat expectations—EPS of $0.20 versus a $0.16 consensus and revenue of $81.2M versus $79.7M.
• The company declared a quarterly dividend of $0.035 (annualized $0.14, ~0.6% yield; record date May 18, pay date May 29) and authorized a $10M share repurchase program (about 1.7% of shares).
• Management guided FY2026 revenue to roughly $323M–$330M, near consensus, while the stock trades at a relatively rich valuation (trailing P/E ~38.8), which could limit upside if future results or guidance disappoint.

HealthStream, Inc. (NASDAQ:HSTM - Get Free Report)'s share price rose 11.7% during mid-day trading on Tuesday after the company announced better than expected quarterly earnings. The company traded as high as $23.61 and last traded at $23.73. Approximately 191,725 shares were traded during trading, a decline of 37% from the average daily volume of 306,424 shares. The stock had previously closed at $21.25.

The technology company reported $0.20 earnings per share for the quarter, beating the consensus estimate of $0.16 by $0.04. The firm had revenue of $81.20 million during the quarter, compared to analyst estimates of $79.68 million. HealthStream had a return on equity of 5.98% and a net margin of 6.03%.

HealthStream Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, May 29th. Investors of record on Monday, May 18th will be issued a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Monday, May 18th. HealthStream's dividend payout ratio is 22.95%.

HealthStream announced that its board has authorized a share repurchase program on Friday, March 13th that permits the company to repurchase $10.00 million in shares. This repurchase authorization permits the technology company to purchase up to 1.7% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company's board of directors believes its stock is undervalued.

HealthStream News Summary

Here are the key news stories impacting HealthStream this week:

• Positive Sentiment: Q1 2026 results beat expectations — EPS $0.20 vs. $0.16 consensus; revenue $81.2M vs. $79.7M consensus; operating income and net income improved, signaling stronger profitability and growth momentum. HealthStream Announces First Quarter 2026 Results
• Positive Sentiment: Analyst coverage confirms the beat — third‑party recap notes the EPS and revenue beat, reinforcing market confidence in the print. HealthStream (HSTM) Q1 Earnings and Revenues Surpass Estimates
• Positive Sentiment: Dividend declared — $0.035 per share quarterly dividend (annualized ~0.7% yield); record date May 18, pay date May 29. This returns cash to shareholders and may support sentiment among income investors.
• Neutral Sentiment: FY2026 revenue guidance provided as a range of about $323.0M–$330.0M, which brackets the consensus (~$326.2M). The range suggests modest upside but limited visibility; investors should listen for accompanying EPS guidance or margin drivers in the call/transcript. Press Release / Investor Presentation
• Neutral Sentiment: Earnings call / transcript resources — read management commentary for customer trends, churn, backlog, and margin assumptions that will determine whether the beat is sustainable. HealthStream (HSTM) Q1 2026 Earnings Transcript
• Neutral Sentiment: Prior-quarter transcripts for context on strategy and execution (Q4 2025, Q1 2025). Useful for comparing guidance cadence and recurring revenue trends. HealthStream (HSTM) Q4 2025 Earnings Transcript HealthStream (HSTM) Q1 2025 Earnings Transcript
• Negative Sentiment: Valuation appears rich — trailing P/E is elevated (~38x) versus growth, which could limit upside if future quarters don’t sustain the current beat or if guidance disappoints. Investors sensitive to multiple compression should monitor guidance detail and margin trajectory.

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on HSTM. Canaccord Genuity Group set a $25.00 price objective on HealthStream in a research report on Thursday, January 8th. Weiss Ratings downgraded HealthStream from a "hold (c-)" rating to a "sell (d+)" rating in a research report on Wednesday, March 18th. Finally, Citigroup reiterated a "market perform" rating on shares of HealthStream in a research report on Tuesday, January 6th. Two investment analysts have rated the stock with a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Reduce" and an average target price of $25.00.

Institutional Investors Weigh In On HealthStream

Several hedge funds and other institutional investors have recently made changes to their positions in HSTM. JPMorgan Chase & Co. grew its position in shares of HealthStream by 302.0% in the second quarter. JPMorgan Chase & Co. now owns 247,905 shares of the technology company's stock valued at $6,860,000 after purchasing an additional 186,231 shares during the last quarter. Qube Research & Technologies Ltd lifted its stake in shares of HealthStream by 77.3% in the second quarter. Qube Research & Technologies Ltd now owns 251,953 shares of the technology company's stock valued at $6,972,000 after buying an additional 109,883 shares during the period. Numerai GP LLC bought a new stake in shares of HealthStream in the third quarter valued at about $1,911,000. Jane Street Group LLC lifted its stake in shares of HealthStream by 180.4% in the fourth quarter. Jane Street Group LLC now owns 96,887 shares of the technology company's stock valued at $2,235,000 after buying an additional 62,339 shares during the period. Finally, Inspire Investing LLC lifted its stake in shares of HealthStream by 352.3% in the fourth quarter. Inspire Investing LLC now owns 72,522 shares of the technology company's stock valued at $1,673,000 after buying an additional 56,487 shares during the period. 69.58% of the stock is owned by institutional investors and hedge funds.

HealthStream Price Performance

The company's 50 day moving average is $21.04 and its two-hundred day moving average is $22.64. The firm has a market cap of $697.43 million, a P/E ratio of 38.77, a PEG ratio of 2.38 and a beta of 0.41.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream's platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company's core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.